A型血胃病患者更易得胃癌

2015-02-10 伊文 人民网

现代人生活节奏快,饮食不规律,有胃病的人很多。美国国家癌症中心在最新版的胃癌">胃癌预防建议中明确了相关疾病、基因、饮食和环境会导致居民罹患胃癌的风险增高。其中提到,5种胃病患者的胃癌发病风险更高。 据北京和睦家医院消化内科医生纪开宇介绍,在最新版的胃癌预防建议中,美国国家癌症中心提醒说,增加胃癌风险的5种疾病因素包括:胃内幽门螺杆菌的感染;肠上皮化生;慢性萎缩性胃炎;维生素B12缺乏导致

现代人生活节奏快,饮食不规律,有胃病的人很多。美国国家癌症中心在最新版的胃癌">胃癌预防建议中明确了相关疾病、基因、饮食和环境会导致居民罹患胃癌的风险增高。其中提到,5种胃病患者的胃癌发病风险更高。

据北京和睦家医院消化内科医生纪开宇介绍,在最新版的胃癌预防建议中,美国国家癌症中心提醒说,增加胃癌风险的5种疾病因素包括:胃内幽门螺杆菌的感染;肠上皮化生;慢性萎缩性胃炎;维生素B12缺乏导致的恶性贫血;胃息肉。

胃癌的基因因素亦不可忽略,如父母、兄弟姐妹等直系亲属患有胃癌,则本人患胃癌的风险高。A型血相对其他血型者患胃癌的风险更高。

此外,饮食问题也可能使人们罹患胃癌的风险增加:例如食谱中蔬菜和水果比例少;摄入盐分过多;过多食用熏烤的食物;食物加工方式不恰当等等。

接触的环境也可能增加人们患上胃癌的风险,例如接触放射线和放射物质;长期在橡胶和煤炭工业环境下工作,以及生活在胃癌高发地区。

那么,如何降低胃癌风险?纪开宇表示,应当从生活习惯入手。

1. 戒烟

烟草中含有多种致癌物质,吸烟会促进、强化胃黏膜的攻击因素,如胃酸分泌会增多等。随着戒烟的时间延长,胃癌风险会进一步降低。

2. 防治幽门螺旋杆菌感染

幽门螺杆菌的慢性感染增加胃癌风险,随感染的持续可能使胃粘膜细胞发生变化和恶化从而导致胃癌。幽门螺旋杆菌是后天传染的,预防的关键是把好“病从口入”这一关。

3. 改善饮食

饮食改善是否能减少胃癌的发病风险,目前还需要更进一步的研究。一些研究认为饮食情况对降低胃癌风险有所改善,例如富含维生素C和胡萝卜素的蔬菜和水果可减少胃癌的风险;还有一些研究认为补充全麦谷类食物、类胡萝卜素、绿茶和大蒜素可能会减少胃癌风险。还有人认为减少盐分摄入可能会降低人们罹患胃癌的风险,美国许多人因为控制和治疗高血压而减少盐分摄入,带来的另外的好处是美国的胃癌发病率同时下降。但需要注意的是,这些因素可能需要更多的证据证明。

4. 特定营养素补充

食物中添加特定的营养素,例如某些维生素,矿物质和其他食品添加物的摄入可能会改善胃癌的发病风险。中国的一项有关食物中添加beta胡萝卜素,维生素E和硒的研究显示了较低的胃癌的死亡率。这有可能包含了那些本来就在他们的日常饮食里缺乏这些营养素的患者。并不能确定在那些已经有健康饮食的人增加食物的添加营养素会产生同样的结果。其他的有关研究还不能证明摄入食品添加营养素如beta 胡萝卜素,维生素C,维生素E,或者硒可以减少胃癌的风险。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1678123, encodeId=339f16e812314, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue May 26 10:07:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16882, encodeId=618c1688250, content=学习了,以后在观察看看!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Tue Feb 24 11:17:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16765, encodeId=d27016e65f1, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:40:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16091, encodeId=14ad160913d, content=我觉得应该只是为数不多的人吧!只可以说是易患, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Mon Feb 16 17:42:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15816, encodeId=8f261581691, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:10:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15584, encodeId=d25c15584b2, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:15:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532479, encodeId=860515324e96f, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Thu Feb 12 00:07:00 CST 2015, time=2015-02-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1678123, encodeId=339f16e812314, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue May 26 10:07:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16882, encodeId=618c1688250, content=学习了,以后在观察看看!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Tue Feb 24 11:17:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16765, encodeId=d27016e65f1, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:40:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16091, encodeId=14ad160913d, content=我觉得应该只是为数不多的人吧!只可以说是易患, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Mon Feb 16 17:42:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15816, encodeId=8f261581691, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:10:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15584, encodeId=d25c15584b2, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:15:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532479, encodeId=860515324e96f, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Thu Feb 12 00:07:00 CST 2015, time=2015-02-12, status=1, ipAttribution=)]
    2015-02-24 xjtumed10

    学习了,以后在观察看看!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1678123, encodeId=339f16e812314, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue May 26 10:07:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16882, encodeId=618c1688250, content=学习了,以后在观察看看!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Tue Feb 24 11:17:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16765, encodeId=d27016e65f1, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:40:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16091, encodeId=14ad160913d, content=我觉得应该只是为数不多的人吧!只可以说是易患, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Mon Feb 16 17:42:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15816, encodeId=8f261581691, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:10:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15584, encodeId=d25c15584b2, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:15:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532479, encodeId=860515324e96f, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Thu Feb 12 00:07:00 CST 2015, time=2015-02-12, status=1, ipAttribution=)]
    2015-02-23 orthoW

    不错的文章,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1678123, encodeId=339f16e812314, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue May 26 10:07:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16882, encodeId=618c1688250, content=学习了,以后在观察看看!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Tue Feb 24 11:17:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16765, encodeId=d27016e65f1, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:40:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16091, encodeId=14ad160913d, content=我觉得应该只是为数不多的人吧!只可以说是易患, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Mon Feb 16 17:42:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15816, encodeId=8f261581691, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:10:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15584, encodeId=d25c15584b2, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:15:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532479, encodeId=860515324e96f, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Thu Feb 12 00:07:00 CST 2015, time=2015-02-12, status=1, ipAttribution=)]
    2015-02-16 acount

    我觉得应该只是为数不多的人吧!只可以说是易患

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1678123, encodeId=339f16e812314, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue May 26 10:07:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16882, encodeId=618c1688250, content=学习了,以后在观察看看!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Tue Feb 24 11:17:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16765, encodeId=d27016e65f1, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:40:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16091, encodeId=14ad160913d, content=我觉得应该只是为数不多的人吧!只可以说是易患, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Mon Feb 16 17:42:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15816, encodeId=8f261581691, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:10:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15584, encodeId=d25c15584b2, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:15:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532479, encodeId=860515324e96f, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Thu Feb 12 00:07:00 CST 2015, time=2015-02-12, status=1, ipAttribution=)]
    2015-02-16 windmilL1989

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1678123, encodeId=339f16e812314, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue May 26 10:07:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16882, encodeId=618c1688250, content=学习了,以后在观察看看!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Tue Feb 24 11:17:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16765, encodeId=d27016e65f1, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:40:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16091, encodeId=14ad160913d, content=我觉得应该只是为数不多的人吧!只可以说是易患, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Mon Feb 16 17:42:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15816, encodeId=8f261581691, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:10:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15584, encodeId=d25c15584b2, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:15:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532479, encodeId=860515324e96f, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Thu Feb 12 00:07:00 CST 2015, time=2015-02-12, status=1, ipAttribution=)]
    2015-02-16 jianlion

    是不是哦

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1678123, encodeId=339f16e812314, content=<a href='/topic/show?id=7df63110d5' target=_blank style='color:#2F92EE;'>#A型血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3110, encryptionId=7df63110d5, topicName=A型血)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Tue May 26 10:07:00 CST 2015, time=2015-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16882, encodeId=618c1688250, content=学习了,以后在观察看看!, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25f71612570, createdName=xjtumed10, createdTime=Tue Feb 24 11:17:00 CST 2015, time=2015-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16765, encodeId=d27016e65f1, content=不错的文章,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=174, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2fb1607679, createdName=orthoW, createdTime=Mon Feb 23 11:40:00 CST 2015, time=2015-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=16091, encodeId=14ad160913d, content=我觉得应该只是为数不多的人吧!只可以说是易患, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Mon Feb 16 17:42:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15816, encodeId=8f261581691, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c68e1614119, createdName=windmilL1989, createdTime=Mon Feb 16 14:10:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15584, encodeId=d25c15584b2, content=是不是哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:15:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1532479, encodeId=860515324e96f, content=<a href='/topic/show?id=144d832140d' target=_blank style='color:#2F92EE;'>#胃病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83214, encryptionId=144d832140d, topicName=胃病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=975212339878, createdName=xiaoshitou, createdTime=Thu Feb 12 00:07:00 CST 2015, time=2015-02-12, status=1, ipAttribution=)]
    2015-02-12 xiaoshitou

相关资讯

胃癌里程碑:礼来重磅单抗Cyramza获欧盟批准 胃癌二线治疗药物

导读:2014年是礼来最为艰难的一年,数个畅销药遭仿制药重创。而肿瘤学管线中抗癌药Cyramza在今年的表现堪称完美,截至目前已收获FDA 3个批文,并于近日收获欧盟首个批文。业界预测,Cyramza的年销售峰值将突破15亿美元,该药在美欧市场的持续走强,将帮助缓解仿制药冲击导致的销售损失。 礼来(Eli Lilly)近日宣布,欧盟委员会(EC)已批准单抗药物Cyramza(ramuciruma

JCO:D2术后辅助放化疗对肠型胃癌患者或更有效

1月5日,《临床肿瘤学》(J Clin Oncol)杂志在线刊发了韩国大样本Ⅲ期临床研究(ARTIST)的最终研究报告,提示胃癌D2根治术后辅助放化疗与单纯标准的卡培他滨和顺铂辅助化疗均能良好耐受,且预防复发的益处相似。 研究纳入458例接受D2根治术的胃癌患者,随机接受上述两种辅助治疗,中位随访7年,结果显示,两组患者无疾病生存(DFS)和总生存(OS) 相似,但在接受D2根治术的“淋巴结

PD-L1类药物Pembrolizumab用于胃癌安全有效(KEYNOTE-012研究)

抗PD-1单克隆抗体pembrolizumab在转移性胃癌患者中表现出了有潜力的抗肿瘤活性,及可管理的毒性。斯坦福大学医学院肿瘤学主任Ronald Levy教授在2015 ASCO GI第一天上午的口头报告中,公布了KEYNOTE-012研究的这一重要结果(摘要号 3)。 Ronald Levy教授 研究内容 KEYNOTE-012研究纳入了39位肿瘤有PD-L1表达的患者。在供筛选的1

男性食用大量蔬菜可降胃癌的风险

日本国立癌症研究中心的一份新报告说,大量食用蔬菜的日本男性患胃下部癌的风险明显较低,这可能是因为蔬菜中含有的抗氧化成分遏制了胃癌元凶之一的幽门螺杆菌发挥作用。这家研究中心对15万日本人进行了问卷调查,按每天的蔬菜进食量将研究对象分为5组,进行了约11年的跟踪调查。调查结果显示,上述研究对象中有1670人患上了胃癌,其中胃上部(约占胃部总体三分之一)出现恶性肿瘤的病例共计258个,胃下部(约占胃部总

PNAS:郝希山院士绘制胃癌突变图谱

来自天津医科大学、德克萨斯大学MD安德森癌症中心及加州大学圣地亚哥分校等处的研究人员,在新研究中绘制出了中国人群胃癌">胃癌(Gastric cancer)的突变图谱,并探讨了其对于预后和治疗的意义。研究结果发布在1月12日的《美国国家科学院院刊》(PNAS)杂志上。 中国工程院院士、天津医科大学名誉校长郝希山(Xishan Hao)教授、德克萨斯大学MD安德森癌症中心的Wei Zhang

ASCO GI 2015:S-1/顺铂可作为晚期胃癌新辅助化疗方案(COMPASS研究)?

2015年ASCO GI研讨会于1月15日~17日在美国旧金山举行。根据经验即使将S-1作为辅助化疗,III期胃癌预后并不尽如人意。新辅助化疗是一种很有希望的方法,但是它的最佳治疗维持时间和方案尚未确定。在此次会议上,研究人员进行了一项II期试验对局部可切除晚期胃癌的新辅助化疗方案进行比较(COMPASS生存期结果分析)。研究方法研究人员开展了一项随机II期试验,利用一种2×2析因设计,对S-